Skip to main content
VCbacked
Log inGet Started

Omnipulse Biosciences

Cambridge, United States

Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries

$7.0M raised
Dec 2023
Venture - Series Unknown
BiopharmaBiotechnologyHealth Care

Top Investors

Trousdale VenturesKendall Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Omnipulse Biosciences

How much funding has Omnipulse Biosciences raised?
Omnipulse Biosciences has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.
Who are Omnipulse Biosciences's investors?
Omnipulse Biosciences's investors include Trousdale Ventures, Kendall Capital Partners.
Where is Omnipulse Biosciences headquartered?
Omnipulse Biosciences is headquartered in Cambridge, United States.
What does Omnipulse Biosciences do?
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries
What stage is Omnipulse Biosciences at?
Omnipulse Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Omnipulse Biosciences — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/omnipulse-biosciences. Accessed June 3, 2026.
APA
VCBacked. (2023). Omnipulse Biosciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/omnipulse-biosciences
Wikipedia (cite web)
{{cite web |title=Omnipulse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/omnipulse-biosciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego